Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 222
Filter
Add more filters

Country/Region as subject
Publication year range
1.
J Exp Med ; 172(3): 729-36, 1990 Sep 01.
Article in English | MEDLINE | ID: mdl-1974914

ABSTRACT

Amphotropic recombinant retroviruses were generated carrying sequences encoding human adenosine deaminase (ADA). Transcription of the human ADA gene was under control of a hybrid long terminal repeat in which the enhancer from the Moloney murine leukemia virus was replaced by an enhancer from the F101 host-range mutant of polyoma virus. Hemopoietic stem cells in murine bone marrow were infected with this virus under defined culture conditions. As a result, 59% of day-12 colony forming unit spleen (CFU-S) stem cells became infected without any in vitro selection. Infected CFU-S were shown to express human ADA before transplantation and this expression sustained upon in vivo maturation. Mice transplanted with infected bone marrow exhibited human ADA expression in lymphoid, myeloid, and erythroid cell types. Moreover, human ADA expression persisted in secondary and tertiary transplanted recipients showing that human ADA-expressing cells were derived from pluripotent stem cells. These characteristics of our amphotropic viruses make them promising tools in gene therapy protocols for the treatment of severe combined immunodeficiency caused by ADA deficiency. In this respect it is also relevant that the viral vector that served as backbone for the ADA vector was previously shown to be nonleukemogenic.


Subject(s)
Adenosine Deaminase/genetics , Genetic Vectors , Hematopoietic Stem Cell Transplantation , Nucleoside Deaminases/genetics , Retroviridae/genetics , Animals , Blotting, Southern , Bone Marrow Transplantation , Cell Line , Cells, Cultured , DNA/genetics , DNA/isolation & purification , Gene Expression , Humans , Mice , Recombination, Genetic
2.
J Cell Biol ; 131(1): 227-34, 1995 Oct.
Article in English | MEDLINE | ID: mdl-7559779

ABSTRACT

Studies on the molecular mechanisms underlying neuronal differentiation are frequently performed using cell lines established from neuroblastomas. In this study we have used mouse N1E-115 neuroblastoma cells that undergo neuronal differentiation in response to DMSO. During differentiation, cyclin-dependent kinase (cdk) activities decline and phosphorylation of the retinoblastoma gene product (pRb) is lost, leading to the appearance of a pRb-containing E2F DNA-binding complex. The loss of cdk2 activity is due to a decrease in cdk2 abundance whereas loss of cdk4 activity is caused by strong association with the cdk inhibitor (CKI) p27KIP1 and concurrent loss of cdk4 phosphorylation. Moreover, neuronal differentiation can be induced by overexpression of p27KIP1 or pRb, suggesting that inhibition of cdk activity leading to loss of pRb phosphorylation, is the major determinant for neuronal differentiation.


Subject(s)
CDC2-CDC28 Kinases , Carrier Proteins , Cell Cycle Proteins , Cyclin-Dependent Kinases/antagonists & inhibitors , DNA-Binding Proteins , Neuroblastoma/enzymology , Protein Serine-Threonine Kinases/antagonists & inhibitors , Proto-Oncogene Proteins , Tumor Suppressor Proteins , Animals , Base Sequence , Cell Differentiation/physiology , Cell Division/physiology , Cyclin-Dependent Kinase 2 , Cyclin-Dependent Kinase 4 , Cyclin-Dependent Kinase Inhibitor p27 , Cyclin-Dependent Kinases/metabolism , E2F Transcription Factors , Enzyme Inhibitors/metabolism , Mice , Microtubule-Associated Proteins/metabolism , Molecular Sequence Data , Neuroblastoma/pathology , Phosphorylation , Protein Serine-Threonine Kinases/metabolism , Retinoblastoma Protein/metabolism , Retinoblastoma-Binding Protein 1 , Transcription Factor DP1 , Transcription Factors/metabolism , Tumor Cells, Cultured/enzymology
3.
Science ; 235(4795): 1486-8, 1987 Mar 20.
Article in English | MEDLINE | ID: mdl-3823900

ABSTRACT

Expression of the class I transplantation antigens of the major histocompatibility complex (MHC) is suppressed in cells transformed by the oncogenic human adenovirus 12 (Ad12). This suppression of class I antigen expression, which contributes to the tumorigenic phenotype of the transformed cells, has also been observed in some naturally occurring cancers. In the present study, the rate of transcription initiation of class I genes was measured by a nuclear run-on assay in Ad5- and Ad12-transformed cells of three different types. The rate of transcription was the same in all three. The stability of the class I messenger RNA was also examined and found to be the same in all three cell types. The results indicate that in Ad12-transformed cells the suppression is caused by an inhibition of the post-transcriptional processing of class I MHC messenger RNA in the nucleus.


Subject(s)
Cell Transformation, Viral , HLA Antigens/genetics , Adenoviruses, Human , Cell Nucleus/metabolism , Gene Expression Regulation , Humans , RNA Processing, Post-Transcriptional , RNA, Messenger/genetics , Transcription, Genetic
4.
Mol Cell Biol ; 4(11): 2341-6, 1984 Nov.
Article in English | MEDLINE | ID: mdl-6096694

ABSTRACT

Enhanced reactivation (ER) and enhanced mutagenesis (EM) of herpes simplex virus type 1 were studied simultaneously in UV-irradiated stationary cultures of diploid normal human and xeroderma pigmentosum (XP) fibroblasts. Mutagenesis was assayed with unirradiated herpes simplex virus type 1 as a probe in a forward mutation assay (resistance to iododeoxycytidine). Dose-response studies showed that ER increased with the UV dose given to the virus. Optimal reactivation levels were obtained when normal cells and XP variant cells were exposed to a UV dose of 8 J . m-2 and the virus was irradiated with 150 J . m-2. Repair-deficient XP cells of complementation groups A, C, and D showed optimal reactivation levels with a UV dose to the cells of 1.0 J . m-2 and a UV dose to the virus of 40 J . m-2. The time course of appearance of ER and EM was also studied, both in the normal and XP cells. In all cell types except the XP variant cells, EM followed similar kinetics of appearance as did ER. Maximal activities occurred when infection was delayed 1 or 2 days after cell treatment. In XP variant cells, however, maximal expression of the EM function was significantly delayed with respect to ER. The results indicate that ER and EM are transiently expressed in normal and repair-deficient XP cells. Although both phenomena may be triggered by the same cellular event, ER and EM appear to be separate processes that occur independently of each other.


Subject(s)
Mutation , Simplexvirus/genetics , Xeroderma Pigmentosum/genetics , Cell Transformation, Viral , Cells, Cultured , DNA Repair , Humans , Simplexvirus/growth & development , Simplexvirus/radiation effects , Ultraviolet Rays , Virus Activation
5.
Mol Cell Biol ; 9(10): 4312-22, 1989 Oct.
Article in English | MEDLINE | ID: mdl-2555688

ABSTRACT

Expression of a mutant H-ras gene confers a transformed phenotype to rat-1 fibroblasts which is basically independent of exogenous growth factors (GFs). Rat-1 cells induced to express high levels of the normal H-ras gene were also found to display a transformed phenotype. In contrast to cells expressing mutant H-ras, these cells were dependent on GFs. We used this difference in GF dependence to analyze a possible involvement of exogenous GFs in H-ras function. Compared with untransformed rat-1 cells, cells overexpressing normal H-ras displayed an elevated response toward insulinlike growth factor 1 (IGF-1), insulin, and bombesin and an increased sensitivity toward phosphatidic acids. It was found that 8-bromo-cyclic AMP inhibited the responses to all GFs in rat-1 cells but had no effect on mutant-H-ras-transformed cells. In cells overexpressing normal H-ras, 8-bromo-cyclic AMP inhibited the responses to all GFs except those to insulin and IGF-1. This implies that overexpression of normal H-ras in the presence of insulin/IGF-1 is functionally similar to the expression of mutant H-ras, since mutant H-ras can circumvent this block by itself. These and other results strongly suggest a functional linkage between insulin/IGF-1 and normal p21 H-ras.


Subject(s)
Growth Substances/physiology , Oncogene Protein p21(ras)/physiology , 8-Bromo Cyclic Adenosine Monophosphate/pharmacology , Animals , Cell Division/drug effects , Cell Line , Cell Line, Transformed , Cell Transformation, Neoplastic/metabolism , Cyclic AMP/physiology , DNA Replication/drug effects , Gene Expression , Insulin/physiology , Insulin-Like Growth Factor I/physiology , Phosphorylation , Receptor, Insulin/metabolism , Receptors, Cell Surface/metabolism , Receptors, Somatomedin , Signal Transduction/physiology
6.
Mol Cell Biol ; 10(12): 6132-40, 1990 Dec.
Article in English | MEDLINE | ID: mdl-1701014

ABSTRACT

The highly unstable c-myc mRNA has been shown to be stabilized in cells treated with protein synthesis inhibitors. We have studied this phenomenon in an effort to gain more insight into the degradation pathway of this mRNA. Our results indicate that the stabilization of c-myc mRNA in the absence of translation can be fully explained by the inhibition of translation-dependent poly(A) tail shortening. This view is based on the following observations. First, the normally rapid shortening of the c-myc poly(A) tail was slowed down by a translation block. Second, c-myc messengers which carry a short poly(A) tail, as a result of prolonged actinomycin D or 3'-deoxyadenosine treatment, were not stabilized by the inhibition of translation. We propose that c-myc mRNA degradation proceeds in at least two steps. The first step is the shortening of long poly(A) tails. This step requires ongoing translation and thus is responsible for the delay in mRNA degradation observed in the presence of protein synthesis inhibitors. The second step involves rapid degradation of the body of the mRNA, possibly preceded by the removal of the short remainder of the poly(A) tail. This last step is independent of translation.


Subject(s)
Poly A/genetics , Protein Biosynthesis , Proto-Oncogene Proteins c-myc/genetics , RNA, Messenger/genetics , RNA/genetics , Blotting, Northern , Dactinomycin/pharmacology , HeLa Cells/drug effects , HeLa Cells/metabolism , Humans , Kinetics , Protein-Tyrosine Kinases/genetics , Proto-Oncogenes , RNA, Neoplasm/genetics , RNA, Neoplasm/isolation & purification , Transcription, Genetic
7.
Mol Cell Biol ; 4(2): 324-8, 1984 Feb.
Article in English | MEDLINE | ID: mdl-6700594

ABSTRACT

Human and rat cells transfected with UV-irradiated linear double-stranded DNA from calf thymus displayed a mutator activity. This phenotype was identified by growing a lytic thermosensitive single-stranded DNA virus (parvovirus H-1) in those cells and determining viral reversion frequencies. Likewise, exogenous UV-irradiated closed circular DNAs, either double-stranded (simian virus 40) or single-stranded (phi X174), enhanced the ability of recipient cells to mutate parvovirus H-1. The magnitude of mutator activity expression increased along with the number of UV lesions present in the inoculated DNA up to a saturation level. Unirradiated DNA displayed little inducing capacity, irrespective of whether it was single or double stranded. Deprivation of a functional replication origin did not impede UV-irradiated simian virus 40 DNA from providing rat and human cells with a mutator function. Our data suggest that in mammalian cells a trans-acting mutagenic signal might be generated from UV-irradiated DNA without the necessity for damaged DNA to replicate.


Subject(s)
DNA/radiation effects , Mutation , Parvoviridae/genetics , Transfection , Animals , Cells, Cultured , DNA/biosynthesis , Humans , Phenotype , Rats , Ultraviolet Rays
8.
Mol Cell Biol ; 14(6): 4126-34, 1994 Jun.
Article in English | MEDLINE | ID: mdl-8196650

ABSTRACT

The human ERCC3 gene, which corrects specifically the nucleotide excision repair defect in human xeroderma pigmentosum group B and cross-complements the repair deficiency in rodent UV-sensitive mutants of group 3, encodes a presumed DNA helicase that is identical to the p89 subunit of the general transcription factor TFIIH/BTF2. To examine the significance of the postulated functional domains in ERCC3, we have introduced mutations in the ERCC3 cDNA by means of site-specific mutagenesis and have determined the repair capacity of each mutant to complement the UV-sensitive phenotype of rodent group 3 cells. A conservative substitution of arginine for the invariant lysine residue in the ATPase motif (helicase domain I), six deletion mutations in the other helicase domains, and a deletion in the potential helix-turn-helix DNA-binding motif fail to complement the ERCC3 excision repair defect of rodent group 3 mutants, which implies that the helicase domains as well as the potential DNA-binding motif are required for the repair function of ERCC3. Analysis of carboxy-terminal deletions suggests that the carboxy-terminal exon may comprise a distinct determinant for the DNA repair function. In addition, we show that a functional epitope-tagged version of ERCC3 accumulates in the nucleus. Deletion of the putative nuclear location signal impairs neither the nuclear location nor the repair function, indicating that other sequences may (also) be involved in translocation of ERCC3 to the nucleus.


Subject(s)
DNA Mutational Analysis , DNA Repair , DNA-Binding Proteins/biosynthesis , DNA-Binding Proteins/genetics , Drosophila Proteins , Transcription, Genetic , Xeroderma Pigmentosum/genetics , Amino Acid Sequence , Animals , Base Sequence , CHO Cells , Cell Survival/radiation effects , Cricetinae , Dose-Response Relationship, Radiation , Drosophila melanogaster/genetics , Helix-Loop-Helix Motifs/genetics , Humans , Mice , Molecular Sequence Data , Oligodeoxyribonucleotides , Point Mutation , Restriction Mapping , Rodentia , Sequence Deletion , Sequence Homology, Amino Acid , Transfection , Ultraviolet Rays
9.
Mol Cell Biol ; 16(8): 4264-72, 1996 Aug.
Article in English | MEDLINE | ID: mdl-8754827

ABSTRACT

Expression of the human blood-clotting factor VIII (FVIII) cDNA is hampered by the presence of sequences located in the coding region that repress transcription. We have previously identified a 305-bp fragment within the FVIII cDNA that is involved in the repression (R.C. Hoeben, F.J. Fallaux, S.J. Cramer, D.J.M. van den Wollenberg, H. van Ormondt, E. Briet, and A.J. van der Eb, Blood 85:2447-2454, 1995). Here, we show that this 305-bp region of FVIII cDNA contains sequences that resemble the yeast (Saccharomyces cerevisiae) autonomously replicating sequence consensus. Two of these DNA elements coincide with AT-rich sequences that are often found in matrix attachment regions or scaffold-attached regions. One of these elements, consisting of nucleotides 1569 to 1600 of the FVIII cDNA (nucleotide numbering is according to the system of Wood et al. (W.I. Wood, D.J. Capon, C.C. Simonsen, D.L. Eaton, J. Gitschier, D. Keyt, P.H. Seeburg, D.H. Smith, P. Hollingshead, K.L. Wion, et al., Nature [London] 312:330-337,1984), binds a nuclear factor in vitro but loses this capacity after four of its base pairs have been changed. A synthetic heptamer of this segment can repress the expression of a chloramphenicol acetyltransferase (CAT) reporter gene and also loses this capacity upon mutation. Furthermore, we demonstrate that repression by FVIII sequences can be relieved by sodium butyrate. We demonstrate that the synthetic heptamer (FVIII nucleotides 1569 to 1600), when placed upstream of the Moloney murine leukemia virus long terminal repeat promoter that drives the CAT reporter, can render the CAT reporter inducible by butyrate. This effect was absent when the same element was mutated. The stimulatory effect of butyrate could not be attributed to butyrate-responsive elements in the studied long terminal repeat promoters. Our data provide a functional characterization of the sequences that repress expression of the FVIII cDNA. These data also suggest a link between transcriptional repression by FVIII cDNA elements and the stimulatory effect of butyrate on FVIII cDNA expression.


Subject(s)
Butyrates/pharmacology , Factor VIII/genetics , Gene Expression Regulation , RNA, Messenger/genetics , Saccharomyces cerevisiae Proteins , Schizosaccharomyces pombe Proteins , Transcription Factors , Base Sequence , DNA Replication , DNA-Binding Proteins/metabolism , Gene Expression Regulation/drug effects , Humans , Molecular Sequence Data , Nuclear Matrix/metabolism , Nuclear Proteins/metabolism , RNA, Messenger/metabolism , RNA-Binding Proteins/metabolism , Regulatory Sequences, Nucleic Acid , Transcription, Genetic/drug effects
10.
Mol Cell Biol ; 16(5): 2101-9, 1996 May.
Article in English | MEDLINE | ID: mdl-8628276

ABSTRACT

p53 stimulates the transcription of a number of genes, such as MDM2, Waf1, and GADD45. We and others have shown previously that this activity of p53 can be inhibited by adenovirus type 2 or 12 large E1B proteins. Here we show that the adenovirus E1A proteins also can repress the stimulation of transcription by p53, both in transient transfections and in stably transfected cell lines. The inhibition by E1A occurs without a significant effect on the DNA-binding capacity of p53. Furthermore, the activity of a fusion protein containing the N-terminal part of p53 linked to the GAL4 DNA-binding domain can be suppressed by E1A. This indicates that E1A affects the transcription activation domain of p53, although tryptic phosphopeptide mapping revealed that the level of phosphorylation of this domain does not change significantly in E1A-expressing cell lines. Gel filtration studies, however, showed p53 to be present in complexes of increased molecular weight as a result of E1A expression. Apparently, E1A can cause increased homo- or hetero-oligomerization of p53, which might result in the inactivation of the transcription activation domain of p53. Additionally, we found that transfectants stably expressing E1A have lost the ability to arrest in G1 after DNA damage, indicating that E1A can abolish the normal biological function of p53.


Subject(s)
Adenovirus E1A Proteins/metabolism , Adenoviruses, Human/genetics , Saccharomyces cerevisiae Proteins , Transcription Factors , Transcriptional Activation , Tumor Suppressor Protein p53/metabolism , Adenoviruses, Human/metabolism , Base Sequence , Cell Cycle , Cell Line , Cell Nucleus/metabolism , DNA-Binding Proteins , Fungal Proteins/biosynthesis , Fungal Proteins/metabolism , Humans , Luciferases/biosynthesis , Molecular Sequence Data , Oligonucleotide Probes , Phosphorylation , Recombinant Fusion Proteins/biosynthesis , Recombinant Fusion Proteins/metabolism , Transcription, Genetic , Transfection , Tumor Cells, Cultured , Tumor Suppressor Protein p53/antagonists & inhibitors , Tumor Suppressor Protein p53/biosynthesis
11.
Mol Cell Biol ; 5(11): 3084-91, 1985 Nov.
Article in English | MEDLINE | ID: mdl-2943983

ABSTRACT

The distribution and stability of the cellular tumor antigen p53 were studied in baby rat kidney cells transformed by region E1 sequences of nononcogenic adenovirus (Ad) type 5 (Ad5) or oncogenic type 12 (Ad12). In transformed cells expressing the large E1B T antigen of Ad5, p53 was associated with this T antigen. The complexed proteins were concentrated in a cytoplasmic body, which has been shown to consist of a cluster of 8-nm filaments (A. Zantema et al., Virology 142:44-58, 1985). In transformed cells expressing the E1B region of Ad12, however, no association between the viral large T antigen and p53 was detectable. In the latter case, both proteins were found almost exclusively in the nucleus. The stability of p53 in both Ad5- and Ad12-transformed cells was increased relative to that in primary cells or cells immortalized by the E1A region only. Thus, the increased stability of p53 in Ad-transformed cells is not caused by association with a viral T antigen, but it correlates with expression of E1B and with morphological transformation.


Subject(s)
Adenoviruses, Human/genetics , Antigens, Viral, Tumor/analysis , Neoplasm Proteins/analysis , Oncogene Proteins, Viral/analysis , Phosphoproteins/analysis , Adenovirus Early Proteins , Animals , Antibodies, Monoclonal , Cell Line , Cell Transformation, Viral , Fluorescent Antibody Technique , Kidney , Mice , Mice, Inbred BALB C , Rats , Serotyping , Transfection , Tumor Suppressor Protein p53
12.
Mol Cell Biol ; 10(6): 2570-81, 1990 Jun.
Article in English | MEDLINE | ID: mdl-2111438

ABSTRACT

In this report we present the cloning, partial characterization, and preliminary studies of the biological activity of a human gene, designated ERCC-3, involved in early steps of the nucleotide excision repair pathway. The gene was cloned after genomic DNA transfection of human (HeLa) chromosomal DNA together with dominant marker pSV3gptH to the UV-sensitive, incision-defective Chinese hamster ovary (CHO) mutant 27-1. This mutant belongs to complementation group 3 of repair-deficient rodent mutants. After selection of UV-resistant primary and secondary 27-1 transformants, human sequences associated with the induced UV resistance were rescued in cosmids from the DNA of a secondary transformant by using a linked dominant marker copy and human repetitive DNA as probes. From coinheritance analysis of the ERCC-3 region in independent transformants, we deduce that the gene has a size of 35 to 45 kilobases, of which one essential segment has so far been refractory to cloning. Conserved unique human sequences hybridizing to a 3.0-kilobase mRNA were used to isolate apparently full-length cDNA clones. Upon transfection to 27-1 cells, the ERCC-3 cDNA, inserted in a mammalian expression vector, induced specific and (virtually) complete correction of the UV sensitivity and unscheduled DNA synthesis of mutants of complementation group 3 with very high efficiency. Mutant 27-1 is, unlike other mutants of complementation group 3, also very sensitive toward small alkylating agents. This unique property of the mutant is not corrected by introduction of the ERCC-3 cDNA, indicating that it may be caused by an independent second mutation in another repair function. By hybridization to DNA of a human x rodent hybrid cell panel, the ERCC-3 gene was assigned to chromosome 2, in agreement with data based on cell fusion (L. H. Thompson, A. V. Carrano, K. Sato, E. P. Salazar, B. F. White, S. A. Stewart, J. L. Minkler, and M. J. Siciliano, Somat. Cell. Mol. Genet. 13:539-551, 1987).


Subject(s)
DNA Repair , DNA Replication/radiation effects , Genes , Ultraviolet Rays , Alkylating Agents/pharmacology , Animals , Blotting, Southern , Cell Line , Cloning, Molecular/methods , DNA/genetics , DNA/isolation & purification , DNA Replication/drug effects , Genomic Library , Humans , Kinetics , Methyl Methanesulfonate/pharmacology , Mitomycin , Mitomycins/pharmacology , Mutation , Nucleic Acid Hybridization , Restriction Mapping , Transfection
13.
Mol Cell Biol ; 10(11): 5857-64, 1990 Nov.
Article in English | MEDLINE | ID: mdl-2172787

ABSTRACT

The adenovirus early region 1A (E1A) oncogene interferes with the expression level and activity of the AP-1 transcription factor family. E1A abolished the transactivating function of AP-1 (Jun/Fos), which binds to the 12-O-tetradecanoylphorbol-13-acetate-responsive element of the collagenase gene (collTRE). In contrast, the activity of another member of the AP-1 family that binds to the c-junTRE was not repressed. The mRNA expression of the c-jun gene was, in fact, strongly elevated in various cell types expressing the E1A gene of either adenovirus type 5 (Ad5) or Ad12. The regulation of the junB gene by adenovirus E1A, on the other hand, depended both on the cell type and on the transforming adenovirus serotype. The fact that E1A-induced alterations in the repertoire of AP-1 transcription factors depend on its transforming domain in conserved region 1 suggests that the effects are relevant for the transformation process.


Subject(s)
Adenoviruses, Human/genetics , Cell Transformation, Neoplastic , DNA-Binding Proteins/genetics , Oncogene Proteins, Viral/genetics , Oncogenes , Transcription Factors/genetics , Adenovirus Early Proteins , Animals , Cell Line , Humans , Mutation , Polyomavirus/genetics , Promoter Regions, Genetic , Proto-Oncogene Proteins c-jun , Proto-Oncogenes , RNA, Messenger/genetics , Simian virus 40/genetics
14.
Nucleic Acids Res ; 28(23): E104, 2000 Dec 01.
Article in English | MEDLINE | ID: mdl-11095700

ABSTRACT

Bacteriophage Mu has one of the best studied, most efficient and largest transposition machineries of the prokaryotic world. To harness this attractive integration machinery for use in mammalian cells, we cloned the coding sequences of the phage factors MuA and MuB in a eukaryotic expression cassette and fused them to a FLAG epitope and a SV40-derived nuclear localization signal. We demonstrate that these N-terminal extensions were sufficient to target the Mu proteins to the nucleus, while their function in Escherichia coli was not impeded. In vivo transposition in mammalian cells was analysed by co-transfection of the MuA and MuB expression vectors with a donor construct, which contained a miniMu transposon carrying a Hygromycin-resistance marker (Hyg(R)). In all co-transfections, a significant but moderate (up to 2.7-fold) increase in Hyg(R) colonies was obtained if compared with control experiments in which the MuA vector was omitted. To study whether the increased efficiency was the result of bona fide Mu transposition, integrated vector copies were cloned from 43 monoclonal and one polyclonal cell lines. However, in none of these clones, the junction between the vector and the chromosomal DNA was localized precisely at the border of the Att sites. From our data we conclude that expression of MuA and MuB increases the integration of miniMu vectors in mammalian cells, but that this increase is not the result of bona fide Mu-induced transposition.


Subject(s)
Gene Transfer Techniques , Genetic Therapy/methods , Genetic Vectors/genetics , Bacteriophage mu/genetics , Cell Line, Transformed , DNA Transposable Elements/genetics , DNA, Recombinant , DNA-Binding Proteins/genetics , Escherichia coli/genetics , Escherichia coli/virology , Gene Expression , Genetic Complementation Test , Green Fluorescent Proteins , Humans , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Oligopeptides , Peptides/genetics , Plasmids/genetics , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Transfection , Transposases/genetics , Tumor Cells, Cultured , Viral Proteins/genetics
15.
Cancer Res ; 52(1): 53-7, 1992 Jan 01.
Article in English | MEDLINE | ID: mdl-1309228

ABSTRACT

The dose response of the enhanced reactivation (ER) of herpes simplex virus type 1 has been studied in UV-irradiated normal human skin fibroblasts and fibroblasts from the following hereditary cancer-prone syndromes: retinoblastoma, aniridia, polyposis coli, neurofibromatosis type 1 and 2, dysplastic nevus syndrome, Von Hippel-Lindau syndrome, multiple endocrine neoplasia type 2, and Bloom's syndrome. Surprisingly, much higher levels of ER were observed in all these genetically heterogeneous hereditary disorders than in normal human skin fibroblasts. These results suggest that loss of one allele of putative tumor suppressor genes may activate cellular processes that result in the induction of the ER response, and they support our previous observation suggesting that ER may somehow be related to the process of carcinogenesis (P. J. Abrahams et al., Cancer Res., 48: 6054-6057, 1988).


Subject(s)
Aniridia/microbiology , Bloom Syndrome/microbiology , Dysplastic Nevus Syndrome/microbiology , Neoplastic Syndromes, Hereditary/microbiology , Retinoblastoma/microbiology , Simplexvirus/growth & development , Virus Activation , von Hippel-Lindau Disease/microbiology , Dose-Response Relationship, Radiation , Fibroblasts/microbiology , Fibroblasts/radiation effects , Humans , SOS Response, Genetics
16.
Cancer Res ; 59(12): 3010-5, 1999 Jun 15.
Article in English | MEDLINE | ID: mdl-10383168

ABSTRACT

Apoptin, a protein derived from chicken anemia virus, has previously been shown to induce apoptosis in a p53-independent and Bcl-2-stimulated manner in transformed and tumorigenic human cells but not in normal diploid human cells, suggesting that it is a potential agent for tumor therapy. Here we report that Apoptin can induce apoptosis in UV-C-irradiated diploid skin fibroblasts from individuals with various hereditary cancer-prone syndromes that are characterized by a germ-line mutation in a tumor suppressor gene. The same effect is found when these cells are irradiated with X-rays. In contrast, diploid skin fibroblasts from healthy donors or from individuals with DNA repair disorders are not responsive to Apoptin-induced apoptosis upon UV-C or X-ray irradiation. After transfection of untreated cells, Apoptin is found predominantly in the cytoplasm, whereas in UV-C-exposed Apoptin-responsive cancer-prone cells, it migrates to the nucleus, where it causes rapid apoptosis. Apoptin remains localized in the cytoplasm after UV-C treatment of diploid cells from healthy individuals. The induction of apoptosis by Apoptin in cancer-prone cells with a germ-line mutation in a tumor suppressor gene is UV dose-dependent and transient, just like many other UV-induced processes. These results suggest that Apoptin may be used as a diagnostic tool for detection of individuals with an increased risk for hereditary cancer and premalignant lesions.


Subject(s)
Apoptosis , Capsid Proteins , Capsid/pharmacology , Neoplastic Syndromes, Hereditary/pathology , Viral Proteins/pharmacology , Apoptosis/radiation effects , Cells, Cultured , Chicken anemia virus , DNA Repair/genetics , Dose-Response Relationship, Radiation , Fibroblasts/drug effects , Fibroblasts/radiation effects , Humans , Neoplastic Syndromes, Hereditary/genetics , Skin/drug effects , Skin/radiation effects , Time Factors , Ultraviolet Rays
17.
Cancer Res ; 48(21): 6054-7, 1988 Nov 01.
Article in English | MEDLINE | ID: mdl-2844398

ABSTRACT

The time course of appearance of enhanced reactivation (ER) and enhanced mutagenesis (EM) of herpes simplex virus type 1 were studied in UV-irradiated stationary cultures of xeroderma pigmentosum (XP) fibroblasts. In some of the XP cells EM followed similar kinetics of appearance as ER. Maximal activities occurred when infection was delayed 1 or 2 days after cell treatment. However, in certain XP cells only induction of the EM response was observed, whereas ER was absent. Interestingly, the latter XP cells had been obtained from patients who had not yet developed skin cancer at the time they were described in the literature, whereas the former XP patients had already developed skin tumors. This suggests that the ER response may somehow be involved in the process of oncogenic transformation. Dose-response studies of ER in XP cells from tumor-bearing patients showed that ER is maximally induced with a UV dose of 40 Jm-2 given to the virus. Normal levels of ER were observed in 14 different normal human skin fibroblasts, indicating that the ER- phenotype does not occur in normal cells or at least more rarely than in XP cells.


Subject(s)
Simplexvirus/growth & development , Virus Activation , Xeroderma Pigmentosum/microbiology , Adolescent , Adult , Cells, Cultured , Child , Child, Preschool , DNA Repair , Dose-Response Relationship, Radiation , Female , Humans , Infant , Male , Mutation , Ultraviolet Rays
18.
Cancer Res ; 55(3): 486-9, 1995 Feb 01.
Article in English | MEDLINE | ID: mdl-7834613

ABSTRACT

Previously, we have shown that the chicken anemia virus-derived VP3 ("apoptin") protein induces apoptosis in chicken mononuclear cells. Here, we report that apoptin also induces apoptosis in human osteosarcoma cells, regardless of whether they expressed wild-type, mutant p53, or no p53 at all. Moreover, the nuclear location of apoptin appears to be important for its optimal induction of apoptosis. The fact that apoptin can induce p53-independent apoptosis in human tumor cells makes apoptin a potential candidate for treatment of frequently occurring types of cancer cells that do not contain functional p53.


Subject(s)
Apoptosis/physiology , Capsid Proteins , Capsid/physiology , Tumor Suppressor Protein p53/physiology , Bone Neoplasms , Capsid/biosynthesis , Cell Line , Chicken anemia virus , Fluorescent Antibody Technique , Humans , Kinetics , Osteosarcoma , Recombinant Proteins/biosynthesis , Recombinant Proteins/metabolism , Time Factors , Transfection , Tumor Cells, Cultured , Tumor Suppressor Protein p53/biosynthesis
19.
Cancer Res ; 57(7): 1353-63, 1997 Apr 01.
Article in English | MEDLINE | ID: mdl-9102224

ABSTRACT

The Wilms' tumor 1 gene (WT1) encodes a transcription factor of the zinc-finger family. As a result of alternative RNA splicing, the gene can be expressed as four polypeptides that differ in the presence or absence of a stretch of 17 amino acids just NH2 terminal of the four zinc fingers and a stretch of three amino acids (+/-KTS) between zinc fingers 3 and 4. In this study, cDNA constructs encoding the four human Wilms' tumor 1 splice variants were transiently transfected into the p53-negative Hep3B and the p53-positive HepG2 hepatoma cell lines. Morphological assessment of the WT1-expressing cells showed that the WT1(-KTS) splice variants induced apoptosis in both cell lines, whereas the WT1(+KTS) isoforms did not. The induction of apoptosis by the WT1(-KTS) isoforms appears to be p53 independent in the hepatoma cell lines. Furthermore, it was found that the WT1(-KTS)-induced apoptosis could not be suppressed by coexpression of either the Mr 21,000 E1B, the Bcl-2, or the BAG-1 protein. Coexpression of either the epidermal growth factor receptor or the insulin receptor, however, partially rescued the cells from apoptosis.


Subject(s)
Apoptosis , Carcinoma, Hepatocellular/genetics , DNA-Binding Proteins/genetics , ErbB Receptors/metabolism , Genes, p53 , Liver Neoplasms/genetics , Receptor, Insulin/metabolism , Transcription Factors/genetics , Blotting, Western , DNA-Binding Proteins/metabolism , Fluorescent Antibody Technique, Indirect , Gene Expression Regulation, Neoplastic , Humans , Transcription Factors/metabolism , Transfection , Tumor Cells, Cultured , WT1 Proteins
20.
Cancer Res ; 56(11): 2621-5, 1996 Jun 01.
Article in English | MEDLINE | ID: mdl-8653707

ABSTRACT

The time course of induction of SOS-like stress responses such as enhanced reactivation (ER) and enhanced mutagenesis (EM) has been investigated in UV-C-irradiated skin fibroblasts from a xeroderma pigmentosum (XP) family, using herpes simplex virus type 1 as a probe. Similar ER studies were performed in a Li-Fraumeni syndrome (LFS) family and in a family with a high incidence of breast, ovarian, and colon cancer. In two XP (complementation group B) patients, with a striking absence of skin tumors even at an age of >40 years, only induction of EM was observed, whereas ER was absent (XPER-). The ER- phenotype was inherited from the father, whereas cells from the mother exhibited normal expression of ER and EM. This suggests that the absence of ER is a hereditary trait that is not correlated with a repair-deficient phenotype. Abnormally high levels of ER were observed in UV-C-exposed skin fibroblasts from rive LFS patients. The inheritance of the ER response was studied in one LFS family. High levels of ER were observed only in cells derived from affected individuals carrying one mutated p53 allele, whereas cells from unaffected family members, carrying two wild-type p53 alleles, exhibited normal ER levels. This result shows that abnormally high levels of ER positively correlate with the occurrence of cancer in affected individuals from a LFS family. Interestingly, abnormally high levels of ER were observed in cells from afflicted as well as from unafflicted members of a family with a high incidence of breast, ovarian, colon, and stomach cancer. This suggests that these latter individuals have inherited a mutated, putative predisposing gene, resulting in abnormal expression of ER, but that cancer had not yet developed. The results indicate that the ER response can possibly be used as a prognostic marker to identify carriers in various hereditary cancer-prone syndromes at an early age.


Subject(s)
Breast Neoplasms/genetics , Neoplasms/genetics , Ovarian Neoplasms/genetics , SOS Response, Genetics , Xeroderma Pigmentosum/genetics , Cells, Cultured , DNA, Viral/genetics , Female , Genes, Tumor Suppressor , Herpesvirus 1, Human , Humans , Male , Pedigree , Skin Neoplasms/genetics , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL